Arab Journal of Gastroenterology
Volume 11, Issue 3 , Pages 130-135 , September 2010

Leptin, osteocalcin, and bone mineral density in post-hepatitic liver cirrhosis

  • Hanan M. Ahmed

      Affiliations

    • Department of Internal Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt
    • ,
  • Hala K. El-Shereef

      Affiliations

    • Department of Internal Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt
    • Corresponding Author InformationCorresponding author. Tel.: +20 111188500; fax: +20 882333327.
    • ,
  • Salwa S. El-Gendi

      Affiliations

    • Department of Internal Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt
    • ,
  • Wafaa T. El-Sherif

      Affiliations

    • Department of Clinical Pathology, Faculty of Medicine, Assiut University, Assiut, Egypt
    • ,
  • Madeeha Y. Bakheet

      Affiliations

    • Department of Clinical Pathology, Faculty of Medicine, Assiut University, Assiut, Egypt
    • ,
  • Ghada M. Galal

      Affiliations

    • Tropical Medicine and Gastroentrology, Sohag Faculty of Medicine, South Valley University, Qena, Egypt
    • ,
  • Sherif H. Abdel-Wahab

      Affiliations

    • Department of Clinical Pathology, Faculty of Medicine, Assiut University, Assiut, Egypt
    • ,
  • Omnia Abd El-Moneum

      Affiliations

    • Department of Clinical Pathology, Faculty of Medicine, Assiut University, Assiut, Egypt

Received 3 January 2010 ,Accepted 6 July 2010.

References 

  1. Ormarsdottir S, Ljunggren O, Mallmin H, et al. Inverse relationship between circulating levels of leptin and bone mineral density in chronic liver disease. J Gastroenterol Hepatol. 2001;16(12):1409–1414
  2. Carey EJ, Balan V, Kremers WK, et al. Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem. Liver Transpl. 2003;9(11):1166–1173
  3. Karan MA, Erten N, Tascioglu C, et al. Osteodystrophy in posthepatitic cirrhosis. Yonsei Med J. 2001;42(5):547–552
  4. Lopes RF, Ferreira SAGJ, Coeli CM, et al. Low body mass index and declining sex steroids explain most age-related bone loss in Brazilian men. Osteoporos Int. 2009;20(7):1175–1182
  5. Ziylan YZ, Baltaci AK, Mogulkoc R. Leptin transport in the central nervous system. Cell Biochem Funct. 2009;27(2):63–70
  6. Bolukbas FF, Bolukbas C, Horoz M, et al. Child-Pugh classification dependent alterations in serum leptin levels among cirrhotic patients: a case controlled study. BMC Gastroenterol 2004;4: Art No. 23.
  7. Thomas T. The complex effects of leptin on bone metabolism through multiple pathways. Curr Opin Pharmacol. 2004;4(3):295–300
  8. Ivaska KK, Kakonen SM, Gerdhem P, et al. Urinary osteocalcin as a marker of bone metabolism. Clin Chem. 2005;51(3):618–628
  9. Iwamoto J, Takeda T, Sato Y. Effects of vitamin K2 on osteoporosis. Curr Pharm Des. 2004;10(21):2557–2576
  10. Pugh RN, Murray Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–649
  11. Duarte MP, Farias ML, Coelho HS, et al. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol. 2001;16(9):1022–1027
  12. Chen CC, Wang SS, Jeng FS, et al. Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis?. J Gastroenterol Hepatol. 1996;11(5):417–421
  13. George J, Ganesh HK, Acharya S, et al. Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol. 2009;15(28):3516–3522
  14. Gonzalez-Calvin JL, Gallego-Rojo F, Fernandez-Perez R, et al. Osteoporosis, mineral metabolism and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis. J Clin Endocrinol Metab. 2004;89(9):4325–4330
  15. Nakamuta M, Tada S, Uchimura K, et al. Serum leptin levels in patients with nonalcoholic chronic liver disease. Hepatogastroenterology. 2001;48(38):527–532
  16. Piche T, Vandenbos F, Abakar Mahamat A, et al. The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis C. J Viral Hepat. 2004;11(1):91–96
  17. Testa R, Franceschini R, Giannini E, et al. Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis. J Hepatol. 2000;33(1):33–37
  18. Ellidokuz E, Comlekci A, Ellidokuz H, et al. The role of serum leptin levels in chronic hepatitis C with steatosis. Hepatogastroenterology 2003;50 (Suppl. 2): cclxix–cclxxii.
  19. Comlekci A, Akpinar H, Yesil S, et al. Serum leptin levels in patients with liver cirrhosis and chronic viral hepatitis. Scand J Gastroenterol. 2003;38(7):779–786
  20. Piche T, Gelsi E, Schneider SM, et al. Fatigue is associated with high circulating leptin levels in chronic hepatitis C. Gut. 2002;51(3):434–439
  21. Lin SY, Wang YY, Sheu WH. Increased serum leptin concentrations correlate with soluble tumour necrosis factor receptor levels in patients with cirrhosis. Clin Endocrinol (Oxf). 2002;57(6):805–811
  22. Endres D, Rude RK. Mineral and bone metabolism. In:  Burtis CA,  Ashwwod ER editor. Tietz fundamentals of clinical chemistry. 5th ed.. Philadelphia (PA): WB Saunders; 2001;p. 795–821
  23. Tolman KG, Rej R. Liver function. In:  Burtis CA,  Ashwood ER editor. Tietz fundamentals of clinical chemistry. 5th ed.. Philadelphia (PA): WB Saunders; 2001;p. 747–770
  24. Giouleme OI, Vyzantiadis TA, Nikolaidis NL, et al. Pathogenesis of osteoporosis in liver cirrhosis. Hepatogastroenterology. 2006;53(72):938–943
  25. Goral V, Simsek M, Mete N. Hepatic osteodystrophy and liver cirrhosis. World J Gastroenterol. 2010;16(13):1639–1643
  26. Iki M, Akiba T, Matsumoto T, et al. Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) study. Osteoporos Int. 2004;15(12):981–991
  27. Blain H, Vuillemin A, Blain A, et al. Age-related femoral bone loss in men: evidence for hyperparathyroidism and insulin-like growth factor-1 deficiency. J Gerontol A Biol Sci Med Sci. 2004;59(12):1285–1289
  28. Floreani A, Mega A, Tizian L, et al. Bone metabolism and gonad function in male patients undergoing liver transplantation: a two-year longitudinal study. Osteoporos Int. 2001;12(9):749–754
  29. Salama ZA, Luttfi AN, El-Azizi HM, et al. Evaluation of hepatic osteodystrophy in patients with liver cirrhosis and correlation with severity of liver disease. Arab J Gastroenterol. 2007;18(1):10–14
  30. Nakchbandi IA, van der Merwe SW. Current understanding of osteoporosis associated with liver disease. Nat Rev Gastroenterol Hepatol. 2009;6(11):660–670
  31. Ormarsdottir S, Ljunggren O, Mallmin H, et al. Increased rate of bone loss at the femoral neck in patients with chronic liver disease. Eur J Gastroenterol Hepatol. 2002;14(1):43–48
  32. Takeda S. Central control of bone remodeling. Biochem Biophys Res Commun. 2005;328(3):697–699
  33. Elefteriou F, Takeda S, Ebihara K, et al. Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci USA. 2004;101(9):3258–3263
  34. Coen G. Leptin and bone metabolism. J Nephrol. 2004;17(2):187–189
  35. Ushiroyama T, Ikeda A, Hosotani T, et al. Inverse correlation between serum leptin concentration and vertebral bone density in postmenopausal women. Gynecol Endocrinol. 2003;17(1):31–36
  36. Ruhl CE, Everhart JE. Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res. 2002;17(10):1896–1903

PII: S1687-1979(10)00088-2

doi: 10.1016/j.ajg.2010.07.006

Arab Journal of Gastroenterology
Volume 11, Issue 3 , Pages 130-135 , September 2010

Article Tools

* Image Usage & Resolution